Ali Saad Al-shammari: Exploring the Role of SGLT2 Inhibitors After TAVI
Ali Saad Al-shammari, Physician and Cardiology Researcher, shared a post on LinkedIn about recent article he and his colleagues co-authored, published in European Journal of Clinical Pharmacology, adding:
“Proud to share that our systematic review and meta-analysis has been published in the European Journal of Clinical Pharmacology:
‘Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation:
a GRADE-assessed systematic review and meta-analysis.’
We conducted a PRISMA-guided review of four studies including 12,374 TAVI patients, comparing SGLT2 inhibitors with standard care.
SGLT2 inhibitor therapy was associated with lower:
All-cause mortality: RR 0.62
HF hospitalization: RR 0.67
Myocardial infarction: RR 0.83
Bleeding events: RR 0.81
No significant differences were observed for cardiac death, stroke, pacemaker implantation, or AKI.
While these findings suggest a promising role for SGLT2 inhibitors after TAVI, the evidence remains limited and largely observational. Further randomized trials are needed.
Grateful to all co-authors Khadeeja ali, Yousif Kurmasha, Mohammedsadeq A. Shweliya, Muhammad Shahzaib, Atef Akoum their collaboration.”
Title: Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation: a grade-assessed systematic review and meta-analysis
Authors: Khadeeja Ali Hamzah, Yousif Hameed Kurmasha, Ali Saad Al-Shammari, Mohammedsadeq A Shweliya, Ali Alsajad Hussein Al-Janabi, Muhammad Shahzaib, Atef Akoum, Yasar Sattar
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target
-
Oct 7, 2026, 15:28Amir Samimi: Prognostic Value of Platelet Count in Resected HNSCC
-
Oct 7, 2026, 15:21Eloïse Laouenan: Bridging Immunity and Thrombosis in MVTE
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story